Volume 13 Supplement 4

Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection

Open Access

0222. Major issues and their solutions in the management of HIV and TB — from the laboratory to the patient and population

  • M Schechter1
Journal of the International AIDS Society201013(Suppl 4):O23

DOI: 10.1186/1758-2652-13-S4-O23

Published: 8 November 2010

HIV is the strongest known risk factor for developing active tuberculosis. In individuals with Mycobacterium tuberculosis infection, the risk of developing active disease is 20 or more times greater in persons living with HIV than HIV negatives. Tuberculosis is the most common HIV-associated illness in resource poor settings and the most common opportunistic infection in patients receiving HAART in developed countries. Of the 33 million people estimated to be living with HIV globally in 2008, approximately 1.5 million were also tuberculosis patients. In that same year, tuberculosis was responsible for 25% of all deaths in HIV-infected individuals. Given the synergistic consequences of the two epidemics, has recommended several collaborative activities as part of core HIV and TB prevention, care and treatment services. In this conference, some of the most important recent advances in prevention, diagnosis, and treatment will be critically reviewed.

Authors’ Affiliations

(1)
AIDS Research Laboratory, Hospital Universitario Clementino Fraga Filho, Universidade Federal de Rio de Janeiro

Copyright

© Schechter; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement